Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Karyopharm Therapeutics Inc.
Other
Overview
Contact US
Contributions
Contributors
Contributions
0 Contributors
1 / 0
1 / 0
3 Contributions
1 / 1
1 / 1
No authors found
Announcement
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications
Karyopharm Therapeutics Inc.
PR-12-24-NI-135
Dec 12, 2024
Inducement Grants
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
Karyopharm Therapeutics Inc.
PR-12-24-NI-124
Dec 03, 2024
Hematology
Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
Karyopharm Therapeutics Inc.
PR-11-24-NI-107
Nov 18, 2024
